Interferon alfa-2a overdosage: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Interferon alfa-2a}} {{CMG}} ==Overdosage== There are no reports of overdosage, but repeated large doses of interferon can be associated with profound lethargy, [...") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overdosage== | ==Overdosage== | ||
There are no reports of overdosage, but repeated large doses of interferon can be associated with profound lethargy, | There are no reports of overdosage, but repeated large doses of interferon can be associated with profound lethargy, fatigue, prostration, and coma. Such patients should be hospitalized for observation and appropriate supportive treatment given.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103964s5204lbl.pdf| url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103964s5204lbl.pdf | publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 14:03, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overdosage
There are no reports of overdosage, but repeated large doses of interferon can be associated with profound lethargy, fatigue, prostration, and coma. Such patients should be hospitalized for observation and appropriate supportive treatment given.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103964s5204lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.